To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer ends JV with Hisun, names COO

Pfizer Inc. (NYSE:PFE) sold its 49% stake in Chinese JV Hisun-Pfizer Pharmaceuticals Co. Ltd. to Sapphire I (HK) Holdings Ltd. Hisun-Pfizer was formed in 2012 with Zhejiang Hisun Pharmaceutical Co. Ltd. (Shanghai:600267),

Read the full 327 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE